- Home
- ARWR vs JBLU Comparison
ARWR vs JBLU Comparison
Compare ARWR & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- JBLU
- Stock Information
- Founded
- ARWR 2003
- JBLU 1998
- Country
- ARWR United States
- JBLU United States
- Employees
- ARWR N/A
- JBLU N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- JBLU Air Freight/Delivery Services
- Sector
- ARWR Health Care
- JBLU Consumer Discretionary
- Exchange
- ARWR Nasdaq
- JBLU Nasdaq
- Market Cap
- ARWR 1.8B
- JBLU 2.1B
- IPO Year
- ARWR 1993
- JBLU N/A
- Fundamental
- Price
- ARWR $13.03
- JBLU $4.88
- Analyst Decision
- ARWR Buy
- JBLU Sell
- Analyst Count
- ARWR 11
- JBLU 11
- Target Price
- ARWR $41.44
- JBLU $4.98
- AVG Volume (30 Days)
- ARWR 1.6M
- JBLU 29.7M
- Earning Date
- ARWR 05-12-2025
- JBLU 04-29-2025
- Dividend Yield
- ARWR N/A
- JBLU N/A
- EPS Growth
- ARWR N/A
- JBLU N/A
- EPS
- ARWR N/A
- JBLU N/A
- Revenue
- ARWR $2,500,000.00
- JBLU $9,210,000,000.00
- Revenue This Year
- ARWR $4,380.43
- JBLU $3.42
- Revenue Next Year
- ARWR $64.24
- JBLU $6.62
- P/E Ratio
- ARWR N/A
- JBLU N/A
- Revenue Growth
- ARWR N/A
- JBLU N/A
- 52 Week Low
- ARWR $9.57
- JBLU $3.34
- 52 Week High
- ARWR $30.41
- JBLU $8.31
- Technical
- Relative Strength Index (RSI)
- ARWR 47.38
- JBLU 58.88
- Support Level
- ARWR $12.44
- JBLU $4.35
- Resistance Level
- ARWR $14.97
- JBLU $4.93
- Average True Range (ATR)
- ARWR 0.74
- JBLU 0.26
- MACD
- ARWR 0.11
- JBLU 0.16
- Stochastic Oscillator
- ARWR 37.01
- JBLU 96.27
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The operating segments of company are Domestic & Canada, Caribbean & Latin America and Atlantic. Majority of revenue is generated from Domestic & Canada segment.